INGENUE CARE

Form 483 issued December 6, 2018 · Norwalk, California

Inspection
Nov 16 – Dec 6, 2018
Investigator
Jolanna A. Norton
Observations
2
Pages
4

In short: On December 6, 2018, FDA issued a Form 483 with 2 observations to INGENUE CARE in Norwalk, California after an inspection that ran Nov 16 – Dec 6, 2018. The investigator was Jolanna A. Norton. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.165 (testing and release for distribution).

At a glance

2 of 2 observations on this 483 concern laboratory controls.

Laboratory controls2

Most cited: 21 CFR 211.165 (1×) · 211.166 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory…

  2. 02

    There is no written testing program designed to assess the stability…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at INGENUE CARE?

FDA listed 2 observations on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.165 (testing and release for distribution). The opening words of each observation are shown on this page.

Who inspected INGENUE CARE?

Jolanna A. Norton is named on this Form 483, for the inspection of Nov 16 – Dec 6, 2018. Each investigator has a profile showing what they cite most.

When was INGENUE CARE inspected by FDA?

The inspection ran Nov 16 – Dec 6, 2018, and the Form 483 is dated December 6, 2018.

How do I get the full Form 483 for INGENUE CARE?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free